Express Pharma

Venus Remedies registers 9.22 per cent growth in annual sales for FY 21-22

The company’s annual sales grew from Rs 548.12 crores in FY 2020-21 to Rs 598.65 crores this fiscal

0 294

Venus Remedies has recorded a 9.22 per cent increase in annual sales in 2021-22 as compared to the previous financial year, a company statement notified.

Aided by concerted efforts to build on its export orders, supply chain, distribution network and product portfolio, the annual sales of Venus Remedies grew from Rs 548.12 crores in FY 2020-21 to Rs 598.65 crores this fiscal, the statement said.

Announcing its audited, consolidated and standalone financial results for the year ending 31st March, 2022, Venus Remedies reported a 16.81 per cent increase in operating profit, which has gone up from Rs 53.78 crores last year to Rs 62.82 crores in FY 2021-22, it added.

Further, according to the statement, the company entered several new global markets like Macedonia, the UAE, Ghana, Rwanda, Turkmenistan, Moldova, Ireland, Cuba, Kurdistan, Kuwait and Turkmenistan and Cameroon in FY 2021-22.

- Advertisement -